Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05565950 · ClinicalTrials.gov registry record · Phase 1
AI-09 In Subjects With Glabellar Lines, GL-101
A Phase 1 study, sponsored by Eirion Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT05565950 is a Phase 1 study that has completed, run by Eirion Therapeutics. The registered enrollment target is 72 participants.
The verdict
NCT05565950, a Phase 1 study, has completed, sponsored by Eirion Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
AI-09 In Subjects with Glabellar Lines
Interventions
- BIOLOGICAL Vehicle
- BIOLOGICAL AI-09
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-09-03 |
| Est. Completion | 2024-06-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05565950
The ClinicalTrials.gov registry entry for NCT05565950 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eirion Therapeutics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT05565950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05565950 about?
NCT05565950 is a clinical study titled "AI-09 In Subjects With Glabellar Lines, GL-101". AI-09 In Subjects with Glabellar Lines
What is the current status of trial NCT05565950?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2022-09-03. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT05565950?
The interventions under investigation include: Vehicle (BIOLOGICAL), AI-09 (BIOLOGICAL).
Who is sponsoring clinical trial NCT05565950?
This trial is sponsored by Eirion Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.